Autologous EBV-specific Cytotoxic T Cells in Systemic Lupus Erythematosus: An Innovative Phase I/IIa Clinical Trial

被引：0

作者：

Enfrein, Antoine ^{[1
]}

Clemenceau, Beatrice ^{[2
]}

Saiagh, Soraya ^{[3
]}

Bressollette, Celine ^{[4
]}

Amoura, Zahir ^{[5
]}

Vie, Henri ^{[2
]}

Hamidou, Mohamed ^{[1
]}

机构：

[1] CHU Nantes, Med Interne, Nantes, France

[2] Univ Nantes, Inserm U1232, Nantes, France

[3] CHU Nantes, Unite Therapie Cellulaire & Genique, Nantes, France

[4] CHU Nantes, Lab Virol, Nantes, France

[5] Hop La Pitie Salpetriere, AP HP, Med Interne, Paris, France

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1772

引用

页码：3691 / 3691

页数：1

共 50 条

[41] Effect of iberdomide on cutaneous manifestations in systemic lupus erythematosus: A randomized phase 2 clinical trial
Werth, Victoria P.
Merrill, Joan T.
Furie, Richard
Dorner, Thomas
van Vollenhoven, Ronald
Lipsky, Peter
Weiswasser, Michael
Korish, Shimon
Schafer, Peter H.
Stern, Mark
Li, Stan
Delev, Nikolay
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (03) : 435 - 443
[42] Successful in vitro priming of EBV-specific CD8+ T cells endowed with strong cytotoxic function for prophylaxis or treatment of PTLD in EBV seronegative hosts.
Comoli, P
Locatelli, F
Frasson, C
Basso, S
Labirio, M
Moretta, A
Montagna, D
Ginevri, F
Maccario, R
BLOOD, 2005, 106 (11) : 426A - 427A
[43] A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis
Lunetta, Christian
Lizio, Andrea
Cabona, Corrado
Gerardi, Francesca
Sansone, Valeria Ada
Corbo, Massimo
Scialo, Carlo
Angelucci, Emanuele
Gualandi, Francesca
Marenco, Paola
Grillo, Giovanni
Cairoli, Roberto
Cesana, Clara
Saccardi, Riccardo
Melazzini, Mario Giovanni
Mancardi, Gianluigi
Caponnetto, Claudia
JOURNAL OF NEUROLOGY, 2022, 269 (10) : 5337 - 5346
[44] A phase I/IIa clinical trial of autologous hematopoietic stem cell transplantation in amyotrophic lateral sclerosis
Christian Lunetta
Andrea Lizio
Corrado Cabona
Francesca Gerardi
Valeria Ada Sansone
Massimo Corbo
Carlo Scialò
Emanuele Angelucci
Francesca Gualandi
Paola Marenco
Giovanni Grillo
Roberto Cairoli
Clara Cesana
Riccardo Saccardi
Mario Giovanni Melazzini
Gianluigi Mancardi
Claudia Caponnetto
Journal of Neurology, 2022, 269 : 5337 - 5346
[45] Infusion of autologous Epstein-Barr Virus (EBV)-specific cytotoxic T cells can treat chronic active EBV infection.
Savoldo, B
Huls, HM
Liu, ZS
Volk, HD
Reinke, P
Sabat, R
Babel, N
Jones, JF
Gee, AP
Brenner, MK
Heslop, HE
Rooney, CM
BLOOD, 2001, 98 (11) : 502A - 502A
[46] Towards Gene Therapy for EBV-Associated Post-Transplant Lymphoproliferative Disease: Genetically Modified EBV-Specific Cytotoxic T Lymphocytes Induce Regression of Autologous EBV-Induced Lymphoproliferation Despite Immunosuppression
Ricciardelli, Ida
Blundell, Mike
Brewin, Jennifer
Amrolia, Persis J.
Pule, Martin
MOLECULAR THERAPY, 2014, 22 : S62 - S63
[47] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus.
Albert, DA
Khan, SR
Stansberry, J
Tsai, D
Eisenberg, RA
ARTHRITIS AND RHEUMATISM, 2003, 48 (12): : 3659 - 3659
[48] A phase I trial of rituximab (anti-CD20) for treatment of systemic lupus erythematosus.
Albert, D
Khan, S
Stansberry, J
Kolasinski, S
Tsai, D
Kamoun, M
Eisenberg, R
ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S446 - S447
[49] PiggyBac-mediated Cancer Immunotherapy Using EBV-specific Cytotoxic T-cells Expressing HER2-specific Chimeric Antigen Receptor
Nakazawa, Yozo
Huye, Leslie E.
Salsman, Vita S.
Leen, Ann M.
Ahmed, Nabil
Rollins, Lisa
Dotti, Gianpietro
Gottschalk, Stephen M.
Wilson, Matthew H.
Rooney, Cliona M.
MOLECULAR THERAPY, 2011, 19 (12) : 2133 - 2143
[50] FAILURE OF AUTOLOGOUS MIXED LYMPHOCYTE REACTIONS BETWEEN T AND NON-T CELLS IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS
SAKANE, T
STEINBERG, AD
GREEN, I
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (07) : 3464 - 3468

← 1 2 3 4 5 →